GO:0030073 insulin secretion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030073 insulin secretion is the regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin.
• Glucose is the primary physiological trigger of insulin secretion, but amino acids, fatty acids, and incretin hormones also modulate the process.
• Insulin secretion is a multistep process involving glucose metabolism, ATP-sensitive potassium channel closure, calcium influx, and granule exocytosis.
• Dysregulation of insulin secretion is central to type 2 diabetes and other metabolic disorders.
• Key genes involved include INS, GCK, KCNJ11, ABCC8, and SLC2A2, among others.
• CRISPR-based models (knockout, knock-in, point mutation) are powerful tools to dissect the molecular mechanisms of insulin secretion.
Description
Insulin secretion is a fundamental biological process that maintains glucose homeostasis. The Gene Ontology term GO:0030073 insulin secretion is defined as the regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin. This process occurs primarily in pancreatic beta cells and is essential for normal metabolic function. Defects in insulin secretion contribute to the pathogenesis of diabetes mellitus, making it a major focus of biomedical research. Understanding the molecular mechanisms, genetic regulators, and experimental models of insulin secretion is critical for developing therapeutic strategies. This article provides a comprehensive overview of GO:0030073, integrating authoritative GO data with published literature to support researchers in designing and interpreting studies on insulin secretion.
insulin secretion At A Glance
| GO ID | GO:0030073 |
|---|---|
| GO term | insulin secretion |
| Ontology | biological_process |
| Synonym | None |
| Major function | Regulated release of proinsulin from secretory granules with cleavage to mature insulin |
| Definition source | QuickGO |
| Related processes | Glucose homeostasis, exocytosis, peptide hormone processing |
| Cellular location | Secretory granules of pancreatic beta cells (vertebrates) or insulin-producing cells (insects) |
What Is GO:0030073?
GO:0030073 insulin secretion refers to the regulated release of proinsulin from secretory granules, accompanied by the cleavage of proinsulin to form mature insulin. In vertebrates, this process occurs in the B granules of pancreatic B cells, while in insects it occurs in insulin-producing cells. The term encompasses the entire pathway from granule maturation to exocytosis and is a key component of glucose homeostasis.
Why Is insulin secretion Important in Cell Biology?
Insulin secretion is critical for maintaining blood glucose levels, and its dysregulation is a hallmark of diabetes. Research into GO:0030073 informs our understanding of beta-cell physiology, diabetes pathogenesis, and potential therapeutic targets.
• Central to glucose homeostasis and metabolic health.
• Dysfunction leads to type 2 diabetes and related metabolic disorders.
• Target for anti-diabetic drugs such as sulfonylureas and GLP-1 receptor agonists.
• Involved in the adipoincretin effect linking adipose tissue to insulin secretion.
• Amino acid-stimulated insulin secretion is a path forward in type 2 diabetes research.
• Spatial organization within islets affects insulin secretion dynamics.
• Isolated human islets are a key model but may not fully reflect in vivo function.
• Inhibition of insulin secretion is relevant for conditions like hypoglycemia.
What Happens During insulin secretion?
Glucose Sensing and Metabolism
In simple terms: The beta cell detects glucose and starts breaking it down to generate energy.
Glucose enters the beta cell via GLUT2 (SLC2A2) and is phosphorylated by glucokinase (GCK), leading to increased ATP production. This step is rate-limiting and critical for glucose-stimulated insulin secretion.
Membrane Depolarization and Calcium Influx
In simple terms: The energy signal closes potassium channels, causing the cell to become more positive and allowing calcium to enter.
Increased ATP/ADP ratio closes ATP-sensitive potassium channels (KATP), composed of KCNJ11 and ABCC8 subunits, leading to membrane depolarization and opening of voltage-gated calcium channels. The resulting calcium influx triggers insulin granule exocytosis.
Granule Exocytosis and Proinsulin Processing
In simple terms: Insulin-containing granules fuse with the cell membrane, releasing insulin after cutting the proinsulin precursor.
Proinsulin is packaged into secretory granules where it is cleaved by prohormone convertases to form mature insulin and C-peptide. Upon calcium influx, granules fuse with the plasma membrane and release insulin into the bloodstream.
Amplifying Pathways and Metabolic Regulation
In simple terms: Other signals like amino acids and hormones can boost insulin release beyond glucose alone.
Amino acids, fatty acids, and incretin hormones (e.g., GLP-1) amplify insulin secretion through metabolic and receptor-mediated pathways. The adipoincretin effect links adipostasis with insulin secretion.
Key Genes Involved in GO:0030073 insulin secretion
The following genes are key regulators of insulin secretion, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INS | Encodes insulin; mutations cause diabetes | Target for knockout and knock-in models |
| GCK | Glucose phosphorylation; rate-limiting for glucose sensing | Mutations cause MODY2; studied via point mutations |
| KCNJ11 | Potassium channel subunit; regulates membrane potential | Mutations cause neonatal diabetes; knockout models |
| ABCC8 | Sulfonylurea receptor; regulates KATP channel | Mutations cause hyperinsulinism; knockout models |
| SLC2A2 | Glucose transporter GLUT2; glucose uptake | Knockout models show impaired secretion |
| SLC30A8 | Zinc transporter; insulin granule zinc content | Risk gene for type 2 diabetes; knockout models |
| PCSK1 | Prohormone convertase 1/3; proinsulin processing | Knockout models show proinsulin processing defects |
| PCSK2 | Prohormone convertase 2; proinsulin processing | Knockout models show proinsulin processing defects |
| CACNA1C | Voltage-gated calcium channel; calcium influx | Knockout models show impaired secretion |
| GNAO1 | G protein subunit; modulates secretion | Studied in knockout models |
| ADCYAP1 | PACAP; amplifies insulin secretion | Knockout models show reduced secretion |
| GLP1R | GLP-1 receptor; incretin signaling | Knockout models show impaired secretion |
| FFAR1 | Free fatty acid receptor 1; fatty acid sensing | Knockout models show altered secretion |
| SLC16A1 | Monocarboxylate transporter; pyruvate transport | Mutations cause exercise-induced hyperinsulinism |
| HNF1A | Transcription factor; beta-cell development | Mutations cause MODY3; knockout models |
| HNF4A | Transcription factor; beta-cell function | Mutations cause MODY1; knockout models |
| NEUROD1 | Transcription factor; beta-cell differentiation | Mutations cause MODY6; knockout models |
| PDX1 | Transcription factor; pancreas development | Knockout models show pancreatic agenesis |
How Is insulin secretion Regulated?
Insulin secretion is regulated by multiple mechanisms, including glucose metabolism, hormonal signals (e.g., GLP-1, adipokines), and neural inputs. The adipoincretin effect links adipostasis with insulin secretion. Amino acids also stimulate insulin secretion and are a path forward in type 2 diabetes research. Inhibition of insulin secretion occurs under conditions of hypoglycemia or stress.
insulin secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCK | MODY2; impaired glucose sensing | Knock-in of patient mutations |
| KCNJ11 | Neonatal diabetes; hyperinsulinism | Knockout and point mutation models |
| ABCC8 | Hyperinsulinism; neonatal diabetes | Knockout and point mutation models |
| INS | Neonatal diabetes; insulin mutations | Knock-in of mutations |
| HNF1A | MODY3; beta-cell dysfunction | Knockout models |
Type 2 Diabetes
Type 2 diabetes is characterized by insulin resistance and progressive beta-cell dysfunction, leading to impaired insulin secretion. Genetic and environmental factors contribute to the decline in beta-cell function.
Monogenic Diabetes
Mutations in genes such as GCK, HNF1A, HNF4A, and KCNJ11 cause monogenic forms of diabetes (MODY and neonatal diabetes) through defects in insulin secretion.
Hyperinsulinism
Congenital hyperinsulinism, often caused by mutations in ABCC8 or KCNJ11, leads to excessive insulin secretion and hypoglycemia.
From insulin secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate glucose-stimulated insulin secretion? | Knockout cell line (e.g., INS-1, MIN6) |
| Does a specific mutation in gene Y affect insulin processing? | Point mutation knock-in |
| Can a tagged version of protein Z track granule dynamics? | Tagged knock-in |
| Does overexpression of gene W enhance insulin secretion? | Overexpression cell model |
| What is the role of gene V in islet architecture? | Knockout mouse model |
| How do amino acids modulate insulin secretion? | Primary islets or cell lines |
How to Study the insulin secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Insulin concentration | Quantify secretion from cells or islets |
| Calcium imaging | Intracellular calcium levels | Study triggering pathway |
| Patch-clamp | Ion channel activity | Assess KATP and calcium channel function |
| Western blot | Proinsulin/insulin protein levels | Evaluate processing |
| qPCR | Gene expression | Measure mRNA levels of key genes |
| RNA-seq | Transcriptome | Identify novel regulators |
| CRISPR screening | Gene function | Discover essential genes for secretion |
| Live-cell imaging | Granule dynamics | Track exocytosis |
Glucose-Stimulated Insulin Secretion Assays
Measure insulin release from beta cells or islets in response to glucose. This is the gold standard for assessing beta-cell function.
Calcium Imaging
Monitor intracellular calcium dynamics using fluorescent dyes or genetically encoded indicators to study the triggering pathway.
Electrophysiology
Patch-clamp techniques measure ion channel activity, such as KATP and voltage-gated calcium channels, in beta cells.
Proinsulin Processing Assays
Western blot or ELISA to detect proinsulin and mature insulin, assessing processing efficiency.
How CRISPR Can Be Used to Study GO:0030073 insulin secretion
Knockout
CRISPR knockout of candidate genes in beta-cell lines (e.g., INS-1, MIN6) or primary islets can reveal their role in insulin secretion. For example, knockout of GCK or KCNJ11 impairs glucose-stimulated secretion.
Point Mutation
Introducing patient-specific point mutations (e.g., in INS or ABCC8) via CRISPR allows study of their impact on insulin processing and secretion.
Knock-in
Knock-in of tagged proteins (e.g., GFP-tagged insulin) enables real-time tracking of granule dynamics and secretion.
Overexpression
Overexpression of candidate genes (e.g., GLP1R) can enhance insulin secretion and is useful for gain-of-function studies.
How EDITGENE Supports insulin secretion Research
Researchers studying insulin secretion-related genes often need to determine whether a candidate gene is causally involved in beta-cell function. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for insulin secretion research.
Frequently Asked Questions About insulin secretion
What is insulin secretion?
Insulin secretion is the regulated release of proinsulin from secretory granules accompanied by cleavage to form mature insulin, primarily from pancreatic beta cells.
What genes are involved in insulin secretion?
Key genes include INS, GCK, KCNJ11, ABCC8, SLC2A2, and many others.
How is insulin secretion regulated?
It is regulated by glucose metabolism, hormones like GLP-1, amino acids, and neural signals.
What diseases are associated with defective insulin secretion?
Type 2 diabetes, monogenic diabetes (MODY), and congenital hyperinsulinism.
What methods are used to study insulin secretion?
Glucose-stimulated insulin secretion assays, calcium imaging, electrophysiology, and CRISPR screens.
Can CRISPR be used to study insulin secretion?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect insulin secretion mechanisms.
What is the role of GCK in insulin secretion?
GCK phosphorylates glucose, a rate-limiting step in glucose sensing and insulin secretion.
How do KATP channels regulate insulin secretion?
KATP channels close in response to increased ATP, depolarizing the membrane and triggering calcium influx and secretion.
What is proinsulin processing?
Proinsulin is cleaved by prohormone convertases to form mature insulin and C-peptide within secretory granules.
What is the adipoincretin effect?
It links adipose tissue function with insulin secretion, highlighting the role of adipokines in beta-cell regulation.
Conclusion
GO:0030073 insulin secretion is a vital biological process with profound implications for metabolic health and disease. Understanding its molecular mechanisms and genetic regulators is essential for developing therapies for diabetes and related disorders. CRISPR-based models offer powerful tools to dissect this process and identify new therapeutic targets.
References
- 1. Park SY et al.. 2021. Assessment of Insulin Secretion and Insulin Resistance in Human.. Diabetes Metab J 45(5):641-654 PMID: 34610719
- 2. Ferdaoussi M. 2024. Metabolic and Molecular Amplification of Insulin Secretion.. Adv Anat Embryol Cell Biol 239:117-139 PMID: 39283484
- 3. Arukha AP et al.. 2025. Effect of Akkermansia muciniphila on GLP-1 and Insulin Secretion.. Nutrients 17(15) PMID: 40806100
- 4. Solinas G et al.. 2024. An adipoincretin effect links adipostasis with insulin secretion.. Trends Endocrinol Metab 35(6):466-477 PMID: 38861922
- 5. Kolic J et al.. 2023. Amino acid-stimulated insulin secretion: a path forward in type 2 diabetes.. Amino Acids 55(12):1857-1866 PMID: 37966501
- 6. Hoang Do O et al.. 2015. Insulin secretion from beta cells within intact islets: location matters.. Clin Exp Pharmacol Physiol 42(4):406-14 PMID: 25676261
- 7. Henquin JC. 2021. Glucose-induced insulin secretion in isolated human islets: Does it truly reflect β-cell function in vivo?. Mol Metab 48:101212 PMID: 33737253
- 8. Young A. 2005. Inhibition of insulin secretion.. Adv Pharmacol 52:173-92 PMID: 16492546
